Jonathan Marino
Juan Delgado-Moreira has relocated to Asia within Hamilton Lane’s private equity management services practice. Delgado-Moreira relocates from the firm’s London offices. Prior to joining Hamilton Lane in 2005, Delgado-Moreira worked with Baring Private Equity Partners in London.
William Crouse is joining the board of directors of PreCision Dermatology Inc., a Rhode Island-based maker of over the counter dermatology products. He is a general partner and former Managing Director of HealthCare Ventures, one of the world's largest venture capital firms specializing in biotechnology.
Got Our E-Mails? Get our daily e-mails, with all the PE, VC and staffing updates that are fit to print. Unlocking Value in Private Markets: How is it done? Going Public: Count Oaktree in, too Now Hiring: Morganthaler adds Goines
Vision Capital, the Toronto-based investment firm, appointed Jeffrey T. Roberts as a senior vice president and assistant portfolio manager. He comes after having spent seven years as a real estate analyst with Desjardins Securities.
Affiliates of private equity firms Aurora Capital Group and Ares Management are among a group selling five million shares of listed, Wisconsin-based Douglas Dynamics via a secondary offering, it was announced. Credit Suisse Securities (USA) LLC, Oppenheimer & Co. Inc., Robert W. Baird & Co. Incorporated and Piper Jaffray are acting as underwriters for the offering.
High net worth individuals are in and VC firms are out. That’s the showing from SecondMarket’s Q1 private stock data, which the auction system released today. After making 40% of investments conducted on SecondMarket’s platform in the fourth quarter of 2010, VC firms accounted for none of its transactions to start 2011. High net worth […]
Maybe Larry Page furiously pounded his desk in Mountain View when he learned of the Microsoft-Skype deal. Maybe it really screwed up his morning. Or, maybe, and, possibly more likely, he hit a speed dial key and said “Looks like we’re just going to have to build it now, instead.” In an age of increasingly […]
NOT Going Private: AOL won’t take financial sponsors’ offers Gilt-ed Age: Daily deals site chairman Susan Lyne raps with The Deal Heavy is the Head: Is Goldman’s power waning? The French Mistake: IMF chief Dominque Strauss-Kahn will remain jailed until his next hearing
Newbury Partners, the Connecticut-based private equity secondary market investor, has added Andrew Levy to its team as a managing director. Previously, Levy worked with Auda Private Equity, where he worked on secondaries and co-investments.
Neuronetics, the Pennsylvania-based maker of non-invasive, non-systemic treatments for depression, completed a $30 million Series E financing. New investors Polaris Venture Partners and Pfizer Venture Investments led the round and were joined by previous investors Investor Growth Capital, New Leaf Venture Partners, Interwest Partners, Three Arch Partners, Quaker BioVentures, and Onset Ventures.